JezK

Edit File: 1644996143.M229604P212110.mocha3025.mochahost.com,S=38995,W=39750:2,S

Envelope-to: basir@jack.ngo,
 fatima.qasimi@jack.ngo,
 finance.manager@jack.ngo,
 sadaqat.qahar@jack.ngo
Delivery-date: Wed, 16 Feb 2022 02:22:23 -0500
From: <obaid.shahzad@jack.ngo>
To: <finance.manager@jack.ngo>,
	<sadaqat.qahar@jack.ngo>,
	<basir@jack.ngo>,
	<fatima.qasimi@jack.ngo>
References: <VI1PR01MB5229C308F609C35599EE2961A5209@VI1PR01MB5229.eurprd01.prod.exchangelabs.com>
In-Reply-To: <VI1PR01MB5229C308F609C35599EE2961A5209@VI1PR01MB5229.eurprd01.prod.exchangelabs.com>
Subject: FW: Subject: RE: RE: [EXT] RE: FW: Technical Proposal for Atta Turk National Children Hospital
Date: Wed, 16 Feb 2022 11:52:18 +0430
Message-ID: <007b01d82305$f0855c30$d1901490$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_007C_01D8232B.A87AB6D0"
Thread-Index: AQKHQLqErlxO01DRFb3Vp73bC3Np56s3ikrQ
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_007C_01D8232B.A87AB6D0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_007D_01D8232B.A87AB6D0"

------=_NextPart_001_007D_01D8232B.A87AB6D0
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

FYI

From: DE LARA, Manuel [mailto:delaram@who.int] 
Sent: Wednesday, January 26, 2022 10:05 PM
To: obaid.shahzad@jack.ngo
Cc: 'Nooromari' <nooromari@jack.ngo>; takal@jack.ngo; faiq.sediqi@jack.ngo;
ahmad@jack.ngo; RASHIDI, Ghulam Rabani <rashidirab@who.int>; FAIZY,
Hameedullah <faizyh@who.int>
Subject: Subject: RE: RE: [EXT] RE: FW: Technical Proposal for Atta Turk
National Children Hospital

Dear Dr. Shahzad,

Good evening and hoping that this email finds you very well.

Taking into consideration the current emergency, we at WHO are to grant
restricted procurement process, however the below must be taken into
consideration by the NGO has to consider :

The WHO guidelines and recommendations

1.	Medicines/Finished Pharmaceutical Products (including but not
limited to WHO pre-qualified products);
2.	Biological products including vaccines (including but not limited to
WHO pre-qualified products);
3.	Medical devices and related health products, including in vitro
diagnostic products (including but not limited to WHO pre-qualified
products);
4.	Medical and health kits which also include the above categories of
products.
[1] Operational Principles for Good Pharmaceutical Procurement:
<http://www.who.int/3by5/en/who-edm-par-99-5.pdf>
http://www.who.int/3by5/en/who-edm-par-99-5.pdf
 <http://apps.who.int/medicinedocs/documents/s21492en/s21492en.pdf> Model
Quality Assurance System for Procurement Agencies. WHO Technical Report
Series, No. 986, 2014, Annex 3:
<http://apps.who.int/medicinedocs/documents/s21492en/s21492en.pdf>
http://apps.who.int/medicinedocs/documents/s21492en/s21492en.pdf

Hope that this will be a great help so that we could implement this much
needed support for Atta Turk National Children Hospital.

Dr Manuel de Lara

Public Health Officer- Emergencies

Afghanistan Country Office - WHO

Kabul, Afghanistan.

Mobile/WhatsApp: +93 780005513

Web: www.who.int <https://www.who.int>

Follow WHO on Facebook <https://www.facebook.com/WHO/> | Twitter
<https://twitter.com/WHO> | YouTube <https://www.youtube.com/user/who> |
Instagram <https://www.instagram.com/who/>

From: <mailto:obaid.shahzad@jack.ngo> obaid.shahzad@jack.ngo <
<mailto:obaid.shahzad@jack.ngo> obaid.shahzad@jack.ngo> 
Sent: Saturday, January 22, 2022 6:24 PM
To: DE LARA, Manuel < <mailto:delaram@who.int> delaram@who.int>; FAIZY,
Hameedullah < <mailto:faizyh@who.int> faizyh@who.int>; RASHIDI, Ghulam
Rabani < <mailto:rashidirab@who.int> rashidirab@who.int>
Cc: <mailto:nooromari@jack.ngo> nooromari@jack.ngo; 'takal' <
<mailto:takal@jack.ngo> takal@jack.ngo>; 'faiq.sediqi' <
<mailto:faiq.sediqi@jack.ngo> faiq.sediqi@jack.ngo>;
<mailto:ahmad@jack.ngo> ahmad@jack.ngo
Subject: RE: RE: [EXT] RE: FW: Technical Proposal for Atta Turk National
Children Hospital

Dear WHO colleagues,

Greeting from JACK.

I would like to thank you on behalf of JACK for your new initiative to
support Atta Turk Hospital at Kabul to deliver valuable basic health
services to Afghanistan vulnerable people through a partnership made with
JACK. It is a great pleasure for us to become partners again with your
esteem organization who always supported Afghan people and we will truly put
our extreme efforts to achieve all possible joint objectives. We are sure
that our cooperation will lead to mutual benefits in terms of quality health
services delivery during the project period.

Further, I want to bring your attention related to project operations. As
the project is approved for short term and will be executed in emergency
mechanisms. At one side the procurement of goods and services through
national competitive bids (NCB) though announcement is very time consuming
which seriously affect the service delivery of this short time project. And
at other end the hospital is also in grave need of medicines, medical
supplies, lab regents and other goods and services as approved in the budget
since they are not supported after August 15, 2021 by any party. They are in
short of all the primary goods and services which profoundly interrupted the
health services. To overcome these challenges we needs extremely quick
response to resolve the problems that we could deliver best services at the
very start of the project and achieve the mutual objectives.

Therefore you are kindly requesting to grant us approval for restricted
bidding process as per JACK procurement policy that we could procure all the
goods and services in the budget in compliance with said procedure. We JACK
will be so thankful for all your support and consideration in this regard.

Your soonest response is highly appreciating in advance and looking forward
to hear very positively.

Sincerely yours

Obaidullah Shahzad

Operation Director

JACK

0788918088

------=_NextPart_001_007D_01D8232B.A87AB6D0
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dus-ascii"><meta name=3DGenerator content=3D"Microsoft Word 15 =
(filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1>FYI<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: DE LARA, Manuel =
[mailto:delaram@who.int] Sent: Wednesday, January 26, 2022 =
10:05 PM To: obaid.shahzad@jack.ngo Cc: 'Nooromari' =
&lt;nooromari@jack.ngo&gt;; takal@jack.ngo; faiq.sediqi@jack.ngo; =
ahmad@jack.ngo; RASHIDI, Ghulam Rabani &lt;rashidirab@who.int&gt;; =
FAIZY, Hameedullah &lt;faizyh@who.int&gt; Subject: Subject: =
RE: RE: [EXT] RE: FW: Technical Proposal for Atta Turk National Children =
Hospital<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. =
Shahzad,<o:p></o:p><o:p>&nbsp;</o:p>Good evening and hoping that this email finds you very =
well.<o:p></o:p>Taking into consideration the =
current emergency, we at WHO are to grant restricted procurement =
process, however the below must be taken into consideration by the NGO =
has to consider :<o:p></o:p>The WHO guidelines and =
recommendations<o:p></o:p><ol start=3D1 type=3D1><ol =
start=3D1 type=3D1><li class=3DMsoNormal =
style=3D'color:#444444;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto=
;mso-list:l1 level2 lfo3'>Medicines/Finished Pharmaceutical Products =
&nbsp;(including but not limited to WHO pre-qualified =
products);<o:p></o:p></li><li class=3DMsoNormal =
style=3D'color:#444444;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto=
;mso-list:l1 level2 lfo3'>Biological =
products including vaccines (including but not limited to WHO =
pre-qualified products);<o:p></o:p></li><li class=3DMsoNormal =
style=3D'color:#444444;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto=
;mso-list:l1 level2 lfo3'>Medical =
devices and related health products, &nbsp;including in vitro diagnostic =
products &nbsp;(including but not limited to WHO pre-qualified =
products);<o:p></o:p></li><li class=3DMsoNormal =
style=3D'color:#444444;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto=
;mso-list:l1 level2 lfo3'>Medical and =
health kits which also include the above categories of =
products. [1]&nbsp;Operational Principles for Good =
Pharmaceutical Procurement:&nbsp;<a =
href=3D"http://www.who.int/3by5/en/who-edm-par-99-5.pdf" =
target=3D"_blank">http://www.who.int/3by5/en/who-ed=
m-par-99-5.pdf</a> <a =
href=3D"http://apps.who.int/medicinedocs/documents/s21492en/s21492en.pdf"=
>Model =
Quality Assurance System for Procurement Agencies. WHO Technical Report =
Series, No. 986, 2014, Annex 3</a>:&nbsp;<a =
href=3D"http://apps.who.int/medicinedocs/documents/s21492en/s21492en.pdf"=
 target=3D"_blank">http://apps.who.int/medicinedocs/=
documents/s21492en/s21492en.pdf</a><o:p></o:p></li></ol></o=
l>Hope that this will be a great help so that we =
could implement this much needed support for Atta Turk National Children =
Hospital.<o:p></o:p><o:p>&nbsp;</o:p>Dr Manuel de Lara<o:p></o:p>Public Health Officer- =
Emergencies<o:p></o:p>Afghanistan Country Office - =
WHO<o:p></o:p>Kabul, Afghanistan.<o:p></o:p>Mobile/WhatsApp: +93 780005513<o:p></o:p>Web:&nbsp;<a href=3D"https://www.who.int" =
title=3D"https://www.who.int">www.who.int</a><o:p></o:p>Follow WHO on&nbsp;<a =
href=3D"https://www.facebook.com/WHO/">Facebook</a>&nbsp;|&nbsp;<a =
href=3D"https://twitter.com/WHO">Twitter</a>&nbsp;|&nbsp;<a =
href=3D"https://www.youtube.com/user/who">YouTube</a>&nbsp;|&nbsp;<a =
href=3D"https://www.instagram.com/who/">Instagram</a><o:p></o:p><img border=3D0 width=3D178 height=3D72 =
id=3D"Picture_x0020_10" src=3D"cid:image001.jpg@01D81300.A71BBBD0" =
alt=3D"signature_119413995"><o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 width=3D304 height=3D100 =
id=3D"Picture_x0020_11" src=3D"cid:image003.jpg@01D8232B.A5BD92A0" =
alt=3D"Graphical user interface, application&#10;&#10;Description =
automatically generated"><o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>From: =
<a =
href=3D"mailto:obaid.shahzad@jack.ngo">ob=
aid.shahzad@jack.ngo</a> &lt;<a =
href=3D"mailto:obaid.shahzad@jack.ngo">ob=
aid.shahzad@jack.ngo</a>&gt; Sent: Saturday, =
January 22, 2022 6:24 PM To: DE LARA, Manuel &lt;<a =
href=3D"mailto:delaram@who.int">de=
laram@who.int</a>&gt;; FAIZY, Hameedullah &lt;<a =
href=3D"mailto:faizyh@who.int">fa=
izyh@who.int</a>&gt;; RASHIDI, Ghulam Rabani &lt;<a =
href=3D"mailto:rashidirab@who.int">ra=
shidirab@who.int</a>&gt; Cc: <a =
href=3D"mailto:nooromari@jack.ngo">no=
oromari@jack.ngo</a>; 'takal' &lt;<a =
href=3D"mailto:takal@jack.ngo">ta=
kal@jack.ngo</a>&gt;; 'faiq.sediqi' &lt;<a =
href=3D"mailto:faiq.sediqi@jack.ngo">fa=
iq.sediqi@jack.ngo</a>&gt;; <a =
href=3D"mailto:ahmad@jack.ngo">ah=
mad@jack.ngo</a> Subject: RE: RE: [EXT] RE: FW: =
Technical Proposal for Atta Turk National Children =
Hospital<o:p></o:p><o:p>&nbsp;</o:p>Dear WHO colleagues,<o:p></o:p><o:p>&nbsp;</o:p>Greeting from =
JACK.<o:p></o:p><o:p>&nbsp;</o:p>I would like to thank =
you on behalf of JACK for your new initiative to support Atta Turk =
Hospital at Kabul to deliver valuable basic health services to =
Afghanistan vulnerable people through a partnership made with JACK. It =
is a great pleasure for us to become partners again with your esteem =
organization who always supported Afghan people and we will truly put =
our extreme efforts to achieve all possible joint objectives. We are =
sure that our cooperation will lead to mutual benefits in terms of =
quality health services delivery during the project period. =
<o:p></o:p><o:p>&nbsp;</o:p>Further, I want to bring =
your attention related to project operations. As the project is approved =
for short term and will be executed in emergency mechanisms. At one side =
the procurement of goods and services through national competitive bids =
(NCB) though announcement is very time consuming which seriously affect =
the service delivery of this short time project. And at other end the =
hospital is also in grave need of medicines, medical supplies, lab =
regents and other goods and services as approved in the budget since =
they are not supported after August 15, 2021 by any party. They are in =
short of all the primary goods and services which profoundly interrupted =
the health services. To overcome these challenges we needs extremely =
quick response to resolve the problems that we could deliver best =
services at the very start of the project and achieve the mutual =
objectives. <o:p></o:p><o:p>&nbsp;</o:p>Therefore you are kindly =
requesting to grant us approval for restricted bidding process as per =
JACK procurement policy that we could procure all the goods and services =
in the budget in compliance with said procedure. We JACK will be so =
thankful for all your support and consideration in this =
regard.<o:p></o:p><o:p>&nbsp;</o:p>Your soonest response is =
highly appreciating in advance and looking forward to hear very =
positively.<o:p></o:p><o:p>&nbsp;</o:p>Sincerely yours <o:p></o:p><o:p>&nbsp;</o:p>Obaidullah Shahzad =
<o:p></o:p>Operation Director <o:p></o:p>JACK =
<o:p></o:p>0788918088<o:p></o:p><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_007D_01D8232B.A87AB6D0--

------=_NextPart_000_007C_01D8232B.A87AB6D0
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01D81300.A71BBBD0>
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------=_NextPart_000_007C_01D8232B.A87AB6D0
Content-Type: image/jpeg;
	name="image003.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image003.jpg@01D8232B.A5BD92A0>
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------=_NextPart_000_007C_01D8232B.A87AB6D0--